MENU
+Compare
GNFT
Stock ticker: NASDAQ
AS OF
Jul 3, 02:00 PM (EDT)
Price
$3.80
Change
-$0.09 (-2.31%)
Capitalization
196.8M

GNFT Genfit SA Forecast, Technical & Fundamental Analysis

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology... Show more

Industry: #Biotechnology
GNFT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for GNFT with price predictions
Jul 02, 2025

Aroon Indicator for GNFT shows an upward move is likely

GNFT's Aroon Indicator triggered a bullish signal on June 16, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 91 similar instances where the Aroon Indicator showed a similar pattern. In of the 91 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where GNFT's RSI Oscillator exited the oversold zone, of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 73 cases where GNFT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GNFT advanced for three days, in of 224 cases, the price rose further within the following month. The odds of a continued upward trend are .

GNFT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 06, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on GNFT as a result. In of 117 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

GNFT moved below its 50-day moving average on June 20, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for GNFT crossed bearishly below the 50-day moving average on June 24, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. GNFT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.368) is normal, around the industry mean (16.522). P/E Ratio (109.276) is within average values for comparable stocks, (58.479). GNFT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.315). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (2.444) is also within normal values, averaging (261.553).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GNFT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
GNFT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

GNFT is expected to report earnings to fall 126.20% to 11 cents per share on September 22

Genfit SA GNFT Stock Earnings Reports
Q2'25
Est.
$0.11
Q4'24
Beat
by $0.02
Q2'24
Beat
by $0.25
The last earnings report on April 24 showed earnings per share of -43 cents, beating the estimate of -45 cents. With 330.00 shares outstanding, the current market capitalization sits at 196.80M.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceutical products for the treatment of cardio metabolic and neurodegenerative diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Parc Eurasante
Phone
+33 320164000
Employees
148
Web
https://www.genfit.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADMLF3.700.06
+1.65%
Adriatic Metals PLC
MRZLF0.29N/A
N/A
Mirasol Resources Ltd.
TMRAY15.55N/A
N/A
Tomra Systems A/S/A
GRYCF0.02N/A
N/A
Graycliff Exploration Limited
ELEZY15.68-0.18
-1.13%
Endesa S.A.

GNFT and Stocks

Correlation & Price change

A.I.dvisor tells us that GNFT and CVALF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNFT and CVALF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNFT
1D Price
Change %
GNFT100%
+2.64%
CVALF - GNFT
25%
Poorly correlated
N/A
ORMP - GNFT
25%
Poorly correlated
+2.86%
GLTO - GNFT
25%
Poorly correlated
+3.81%
CAPR - GNFT
24%
Poorly correlated
+3.30%
FENC - GNFT
24%
Poorly correlated
+2.65%
More